Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-01-23
2024-08-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1 Ultrasound-guided Interscalene Block group
In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.
Ultrasound-guided Interscalene Block group
ultrasound guided interscalene block versus combined ultrasound guided shoulder anterior capsular block and suprascapular nerve block for arthroscopic shoulder surgery
Bupivacaine
bupivacaine 0.25%.
group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.
Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
Bupivacaine
bupivacaine 0.25%.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound-guided Interscalene Block group
ultrasound guided interscalene block versus combined ultrasound guided shoulder anterior capsular block and suprascapular nerve block for arthroscopic shoulder surgery
Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
Bupivacaine
bupivacaine 0.25%.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncooperative patient.
* Patient with neurological deficit.
* Patients with respiratory disorders.
* Patient with bleeding disorders.
* Infection at the block injection site.
* Patients with history of allergy to local anesthetics.
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hosameldin Ibrahim Ibrahim Elsayed Eldib
ASSISTANT LECTURER OF ANESTHESIA AND INTENSIVE CARE AND PAIN MEDICINE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Tanta University
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB0010038
Identifier Type: -
Identifier Source: org_study_id